Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.
Journal: Cancer immunology research
Published: April 22, 2025
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.
Journal: Cancer discovery
Published: March 18, 2025
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.
Journal: Cancer discovery
Published: October 18, 2024
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer.
Journal: Cancer cell
Published: September 05, 2024
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform.
Journal: Cell reports. Medicine
Published: November 21, 2023
Targeted Therapy for Non-Small Cell Lung Cancer: First Line and Beyond.
Journal: Hematology/oncology clinics of North America
Published: April 06, 2023
A comprehensive review of DOACs for cancer associated VTE prophylaxis or treatment.
Journal: Postgraduate medicine
Published: July 13, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy.
Journal: Blood advances
Published: February 19, 2021
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.
Journal: Cancer immunology research
Published: January 23, 2019
Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody.
Journal: Oncoimmunology
Published: July 29, 2018
Last Updated: 09/26/2026